Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-002168
Filing Date
2023-01-05
Accepted
2023-01-05 20:47:21
Documents
2
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10056
2 POA DOCUMENT poa.txt EX-24 4029
  Complete submission text file 0001209191-23-002168.txt   15435
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Issuer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0100 Agricultural Production-Crops

Mailing Address 202 COUSTEAU PLACE STE 105 DAVIS CA 95618
Business Address
Schaefer Thomas J. (Reporting) CIK: 0001960808 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37383 | Film No.: 23513374